Publications by authors named "Wayne Furman"

Claim this Profile
I
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III Trial.
Zachary J Kastenberg, Sanjeev A Vasudevan, Lucy Dolmadjian, Max R Langham, Jin Piao, Wayne L Furman

Ann Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Patrick A Thompson, Marcio H Malogolowkin, Wayne L Furman, Jin Piao, Mark D Krailo

Pediatr Blood Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive Pursuit of No Evidence of Disease Status in Hepatoblastoma Improves Survival: An Observational Study.
Andrew M Fleming, Andrew J Murphy, Suraj Sarvode Mothi, Rodrigo B Interiano, Amos Loh, Wayne L Furman

J Pediatr Surg· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective investigation of the relationship between neuroblastoma response to anti-GD2 monoclonal antibodies and exposure to opioids for pain management.
Kyle J Morgan, Andrew Dudas, Wayne L Furman, M Beth McCarville, Barry L Shulkin

Pediatr Blood Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731.
Sanjeev A Vasudevan, Rebecka L Meyers, Milton J Finegold, Dolores López-Terrada, Sarangarajan Ranganathan, Wayne L Furman

J Pediatr Surg· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
Howard M Katzenstein, Marcio H Malogolowkin, Mark D Krailo, Jin Piao, Alexander J Towbin, Wayne L Furman

Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.
Wayne L Furman, Beth McCarville, Barry L Shulkin, Andrew Davidoff, Matthew Krasin

J Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
Angela Trobaugh-Lotrario, Howard M Katzenstein, Sarangarajan Ranganathan, Dolores Lopez-Terrada, Mark D Krailo, Wayne L Furman

J Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma.
Sara A Mansfield, M Beth McCarville, John T Lucas, Matthew J Krasin, Sara M Federico, Wayne L Furman

Ann Surg Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial lung disease in children with Rubinstein-Taybi syndrome.
Lauren Bradford, Mindy K Ross, Jagila Minso, Mateja Cernelc-Kohan, Katayoon Shayan, Wayne Furman

Pediatr Pulmonol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation study.
John C Panetta, Olivia Campagne, Jessica Gartrell, Wayne Furman, Clinton F Stewart

Clin Transl Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors.
Michael W Bishop, Paul R Hutson, Jacquelyn A Hank, Paul M Sondel, Wayne L Furman

MAbs· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction Chemotherapy With an Anti-GD2 Monoclonal Antibody (Dinutuximab) and Cytokines in Children With Newly Diagnosed High-risk Neuroblastoma: A Case Series.
Jessica Gartrell, Barry L Shulkin, Sara Helmig, Kenneth J Caldwell, Wayne Furman

J Pediatr Hematol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibody Therapies for High Risk Neuroblastoma.
Wayne L Furman

Biologics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma.
Rosa Nguyen, Anand G Patel, Lyra M Griffiths, Jason Dapper, Elizabeth A Stewart, Wayne L Furman

Cancer Immunol Immunother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma.
Pattamon Sutthatarn, Cara E Morin, Jessica Gartrell, Wayne L Furman, Max R Langham

Children (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies.
Sara M Federico, Alberto S Pappo, Natasha Sahr, April Sykes, Olivia Campagne, Wayne L Furman

Eur J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours.
Sara M Federico, Kenneth J Caldwell, Mary B McCarville, Vinay M Daryani, Clinton F Stewart, Wayne L Furman

Eur J Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors.
Victor M Santana, Natasha Sahr, Ruth G Tatevossian, Sujuan Jia, Olivia Campagne, Wayne L Furman

Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort.
Carmen L Wilson, Tara M Brinkman, Cathleen Cook, Sujuan Huang, Geehong Hyun, Wayne L Furman

Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial.
Rosa Nguyen, Natasha Sahr, April Sykes, Mary Beth McCarville, Sara M Federico, Wayne L Furman

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine.
Mirko Peitzsch, Elizabeth R Butch, Elizabeth Lovorn, Anastasios Mangelis, Wayne L Furman

Pediatr Blood Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy.
David Yanishevski, M Beth McCarville, Mikhail Doubrovin, Hannah R Spiegl, Xiwen Zhao, Wayne L Furman

J Pediatr Surg· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma.
Rebecca Epperly, Wayne Furman, Melissa Hines, Teresa Santiago, Ying Li

Pediatr Blood Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma.
Wayne L Furman, Sara M Federico, Mary Beth McCarville, Barry L Shulkin, Andrew M Davidoff

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis